GlassScriptPhysician profile
William C Arrington
NPI 1134213812
$4,237.83
in general payments reported to CMS, 2019-2025
28 companies · $375 in 2025
The $375 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $211 · 2021: $208 · 2022: $1,713 · 2023: $558 · 2024: $783 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,715.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,370.91 | 2021-2024 | |
| Medtronic, INC. | $460.21 | 2022-2024 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $349.47 | 2019-2025 | Grafix Pl, Panta 2, Salto Talaris Total Ankle Prosthesis |
| Bioventus LLC | $224.17 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Grt US Holding, INC. | $201.08 | 2022 | |
| Integra Lifesciences Corporation | $195.58 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $177.45 | 2019-2025 | Motoband, Motoband Cp |
| Nevro Corp. | $163.06 | 2022-2024 | Senza |
| Averitas Pharma INC. | $160.53 | 2023-2024 | Qutenza |
| Zimmer Biomet Holdings, INC. | $123.73 | 2019 | |
| Stimlabs LLC | $117.78 | 2025 | Allacor P |
| Stryker Corporation | $104.90 | 2022-2024 | Ortholoc 3di Crosscheck, Prophecy, Ortholoc 2 Lapifuse |
| Biotissue Holdings INC. | $102.45 | 2022-2023 | |
| Kerecis Limited | $84.54 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Convatec INC. | $54.08 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $53.70 | 2021-2025 | Simplimax |
| Horizon Therapeutics Plc | $50.95 | 2020-2022 | |
| Kci USA, INC. | $38.33 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $34.27 | 2024 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $30.10 | 2022 | |
| Treace Medical Concepts, INC. | $29.64 | 2023 | |
| Orthofix Medical, INC. | $21.54 | 2023-2025 | Physio-Stim |
| Abbott Laboratories | $17.42 | 2023 | Proclaim |
| Melinta Therapeutics, LLC | $16.49 | 2019 | |
| Amgen INC. | $16.28 | 2025 | Krystexxa |
| Djo, LLC | $15.42 | 2021 | |
| Tactile Systems Technology INC | $12.05 | 2020 | |
| Medline Industries LP | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Arrington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.